Merck
1970
FOUNDED
PUBLIC
STATUS
50K-55K
EMPLOYEES
MRK
STOCK SYMBOL
62
INVESTMENTS
$132.65
SHARE PRICE
(As of Friday Closing)
Description
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Specialty Chemicals
Stock Exchange
ETR
Primary Office
- Frankfurter Straße 250
- 64293 Darmstadt
- Germany
+49 06151 000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Merck’s full profile, request a free trial.
Merck Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $95.91 - $133.54 | $57.7B | $130.32 | $8.96 | 500K | 435M |
Merck Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 58,087,072 | 56,639,343 | 58,961,749 | 58,723,013 |
| Revenue | 17,662,918 | 17,507,464 | 16,371,756 | 16,618,734 |
| EBITDA | 4,353,123 | 4,191,596 | 4,761,421 | 4,878,103 |
| Net Income | 3,889,497 | 3,981,544 | 2,937,826 | 1,801,911 |
| Total Assets | 46,025,668 | 42,196,294 | 42,734,602 | 40,236,002 |
| Total Debt | 13,724,439 | 10,072,066 | 12,847,614 | 13,111,565 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Merck Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Merck‘s full profile, request access.
Request full access to PitchBookMerck Competitors (53)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
| 00000 | Corporate Backed or Acquired | Leverkusen, Germany | 000000 | 00.00 | 000000000 | 00.00 |
| 00000000000 000000 | Private Equity-Backed | Mexico City, Mexico | 000.00 | 0000000000 | 000.00 | |
| 000000000000000 | Corporation | Brentford, United Kingdom | 000000 | 00000000000 | ||
| 0000000000 | Corporate Backed or Acquired | Baton Rouge, LA | 000000000000 |
Merck Investments & Acquisitions (62)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 13-Nov-2019 | 000000000000000000 | 00000 | Drug Discovery | |
| 000000000 000000 | 10-Oct-2019 | 000000000000000000 | Discovery Tools (Healthcare) | ||
| 000000 00000000000 | 07-Oct-2019 | 000000000000000000 | Outcome Management (Healthcare) | ||
| 000000 000000000 | 07-Oct-2019 | 000000000000000000 | 00.00 | Specialty Chemicals | 0000000 00000000 00.0 |
| Intermolecular | 01-Sep-2019 | Merger/Acquisition | 000.00 | Application Software | 000 00000000 00.0 |
Merck Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 | 07-Sep-2012 | 000000000 00000 00 | 00000 | Completed |
|
| 0000000 0000000000 | 18-Jul-2008 | 00000 00000 00 | 0000 | Completed |
|
| 00000000 | 11-Jun-2007 | 00000 00000 00 | 000.00 | Completed |
|
| 00000 00000000 000 | 08-Jun-2006 | 000000000 00000000 | Completed |
|
|
| Prasfarma | 15-Sep-2005 | Merger/Acquisition | 000.00 | Completed |
Merck Subsidiaries (22)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Versum Materials | Specialty Chemicals | Tempe, AZ | 2015 |
| 0000000000 | Outcome Management (Healthcare) | Kenya | 0000 |
| 00000 0000000000 0 | Accelerator/Incubator | Darmstadt, Germany | 0000 |
| 0000000000 0000000 | Other Software | Evanston, IL | 0000 |
| 0000 00000000 | Business/Productivity Software | Darmstadt, Germany | 0000 |
Merck Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Merck‘s full profile, request access.
Request full access to PitchBookMerck Executive Team (41)
10 Former Executives
You’re viewing 5 of 41 executives. Get the full list »Merck Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 00000000 | Self | Board Member & Chief Executive Officer, Life Science & Performance Materials | 000 0000 | |
| 000000000 00000 00.0 | Merck | Chairman | 000 0000 | |
| 0000 00000000 | Merck | Senior Director, Finance & Board Member | 000 0000 | |
| 000 00000000 00.0 | Merck | Chief Administration Officer & Member of the Executive Board | 000 0000 | |
| 000000 0000000 00.0 | Merck | Member of the Executive Board & Chief Financial Officer | 000 0000 |
2 Former Board Members
You’re viewing 5 of 8 board members. Get the full list »